A research team at Fujita Health University led by Professor Tsuyoshi Miyakawa has uncovered a novel mechanism of cellular plasticity in which repeated neuronal stimulation can durably alter the identity of mature neurons.
NEWNAN, Ga., July 17, 2026 /PRNewswire/ — Poriferous, LLC, a leading global manufacturer of SuᐧPor® craniomaxillofacial and patient-specific implants, has been awarded its patent for its innovative DuraBloc™ technology from the U.S. Patent and Trademark Office (USPTO), U.S. Patent No. 12,653,677, issued on June 16, 2026.
BOSTON, July 16, 2026 /PRNewswire/ — HoneyNaps, an AI-based sleep medicine company, today announced that SOMNUM V3.0, its AI diagnosis software for polysomnography (PSG) analysis, has received U.S. Food and Drug Administration (FDA) clearance under clearance number K253390.
The LightningWire system is designed to support transseptal access in procedures such as atrial fibrillation ablation, left atrial appendage closure and transcatheter mitral interventions.
The disease is projected to become the fifth leading cause of death by 2040 if diagnosis and treatment rates do not improve
Learn how mechanical stretching helped lab-grown vessels sprout and redirect new capillaries, a step toward keeping engineered tissues alive.
Newronika announced today that it secured CE mark for its latest adaptive deep brain stimulation (aDBS) system.
HistoSonics announced today that it received CE mark approval for its Edison non-invasive histotripsy technology platform.
Claria Medical announced today that it received FDA de novo authorization for its Claria system for minimally invasive hysterectomies.
Abbott (NYSE:ABT) announced today that the FDA approved the longer length (76 mm) Esprit BTK drug-eluting scaffold system.